HIV-infected macrophages resist efficient NK cell-mediated killing while preserving inflammatory cytokine responses
Clayton, Kiera L., Mylvaganam, Geetha, Villasmil-Ocando, Alonso, Stuart, Heather, Maus, Marcela V., Rashidian, Mohammad, Ploegh, Hidde L., Walker, Bruce D.
Published in Cell host & microbe (10.03.2021)
Published in Cell host & microbe (10.03.2021)
Get full text
Journal Article
On a path toward a broad-spectrum anti-viral: inhibition of HIV-1 and coronavirus replication by SR kinase inhibitor harmine
Dahal, Subha, Clayton, Kiera, Cabral, Tyler, Cheng, Ran, Jahanshahi, Shahrzad, Ahmed, Choudhary, Koirala, Amrit, Villasmil Ocando, Alonso, Malty, Ramy, Been, Terek, Hernandez, Javier, Mangos, Maria, Shen, David, Babu, Mohan, Calarco, John, Chabot, Benoit, Attisano, Liliana, Houry, Walid A, Cochrane, Alan
Published in Journal of virology (31.10.2023)
Published in Journal of virology (31.10.2023)
Get full text
Journal Article
Opposing roles of CLK SR kinases in controlling HIV-1 gene expression and latency
Dahal, Subha, Clayton, Kiera, Been, Terek, Fernet-Brochu, Raphaële, Ocando, Alonso Villasmil, Balachandran, Ahalya, Poirier, Mikaël, Maldonado, Rebecca Kaddis, Shkreta, Lulzim, Boligan, Kayluz Frias, Guvenc, Furkan, Rahman, Fariha, Branch, Donald, Bell, Brendan, Chabot, Benoit, Gray-Owen, Scott D, Parent, Leslie J, Cochrane, Alan
Published in Retrovirology (19.08.2022)
Published in Retrovirology (19.08.2022)
Get full text
Journal Article
348 TIL engineered with membrane-bound IL15 (cytoTIL15™) are enriched for tumor-associated antigen reactivity and demonstrate pharmacologically tunable expansion and persistence in the presence of TAA
Burga, Rachel A, Ocando, Alonso Villasmil, Aksoy, Arman, Pedro, Kyle, Kulkarni, Gauri, Langley, Meghan, Primack, Benjamin, Ross, Theresa, Young, Violet, Tchaicha, Jeremy, Meulen, Jan ter, Ols, Michelle
Published in Journal for immunotherapy of cancer (01.11.2023)
Published in Journal for immunotherapy of cancer (01.11.2023)
Get full text
Journal Article
166 Genetically engineered tumor-infiltrating lymphocytes (cytoTIL15) exhibit IL-2-independent persistence and anti-tumor efficacy against melanoma in vivo
Burga, Rachel, Khattar, Mithun, Lajoie, Scott, Pedro, Kyle, Foley, Colleen, Ocando, Alonso Villasmil, Tremblay, Jack, Primack, Benjamin, Langley, Meghan, Thornton, Dan, Tam, Stanley, Brideau, Emily, Ross, Theresa, Wilmes, Gwen, Saha, Sunandan, Helmlinger, Gabriel, Tchaicha, Jeremy, Sethi, Dhruv, Ols, Michelle, Vanasse, Gary, Subramanian, Shyam, Meulen, Jan ter
Published in Journal for immunotherapy of cancer (01.11.2021)
Published in Journal for immunotherapy of cancer (01.11.2021)
Get full text
Journal Article
Abstract LB096: IL15-engineered tumor infiltrating lymphocytes (cytoTIL15TM) exhibit activity against autologous tumor cells from multiple solid tumor indications without IL2
Pedro, Kyle D., Burga, Rachel, Ocando, Alonso Villasmil, Langley, Meghan, Kulkarni, Gauri, Ao, Zheng, Primack, Benjamin, Ross, Theresa, Young, Violet, Tchaicha, Jeremy, Ols, Michelle, Meulen, Jan Ter
Published in Cancer research (Chicago, Ill.) (14.04.2023)
Published in Cancer research (Chicago, Ill.) (14.04.2023)
Get full text
Journal Article
Abstract LB212: Allogeneic, IL-2-independent tumor-infiltrating lymphocytes expressing membrane-bound IL-15 (cytoTIL15࣪) eradicate tumors in a melanoma PDX model through recognition of shared tumor antigens
Tchaicha, Jeremy H., Lajoie, Scott, Burga, Rachel, Ross, Theresa, Primack, Benjamin, Langley, Meghan, Young, Violet, Ocando, Alonso Villasmil, Pedro, Kyle, Tremblay, Jack, Kulkarni, Gauri, Khattar, Mithun, Sethi, Dhruv, Ols, Michelle, Helmlinger, Gabriel, Vanasse, Gary, Subramanian, Shyam, ter Meulen, Jan
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Get full text
Journal Article